547 related articles for article (PubMed ID: 28213094)
1. Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling.
Sok MCP; Tria MC; Olingy CE; San Emeterio CL; Botchwey EA
Acta Biomater; 2017 Apr; 53():109-122. PubMed ID: 28213094
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration.
Shi J; Zhang X; Jiang L; Zhang L; Dong Y; Midgley AC; Kong D; Wang S
Acta Biomater; 2019 Oct; 97():360-373. PubMed ID: 31351251
[TBL] [Abstract][Full Text] [Related]
3. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS
J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
Luo B; Han F; Xu K; Wang J; Liu Z; Shen Z; Li J; Liu Y; Jiang M; Zhang ZY; Zhang Z
J Neurosci; 2016 Sep; 36(37):9590-603. PubMed ID: 27629711
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic anti-inflammatory nano-capsule serves as a cytokine blocker and M2 polarization inducer for bone tissue repair.
Yin C; Zhao Q; Li W; Zhao Z; Wang J; Deng T; Zhang P; Shen K; Li Z; Zhang Y
Acta Biomater; 2020 Jan; 102():416-426. PubMed ID: 31760223
[TBL] [Abstract][Full Text] [Related]
6. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.
Tang H; Liu Y; Yan C; Petasis NA; Serhan CN; Gao H
J Immunol; 2014 Oct; 193(7):3769-78. PubMed ID: 25172497
[TBL] [Abstract][Full Text] [Related]
7. Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning.
Ogle ME; Sefcik LS; Awojoodu AO; Chiappa NF; Lynch K; Peirce-Cottler S; Botchwey EA
Acta Biomater; 2014 Nov; 10(11):4704-4714. PubMed ID: 25128750
[TBL] [Abstract][Full Text] [Related]
8. Development of an immunomodulatory biomaterial: using resolvin D1 to modulate inflammation.
Vasconcelos DP; Costa M; Amaral IF; Barbosa MA; Águas AP; Barbosa JN
Biomaterials; 2015; 53():566-73. PubMed ID: 25890752
[TBL] [Abstract][Full Text] [Related]
9. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.
Hsiao HM; Sapinoro RE; Thatcher TH; Croasdell A; Levy EP; Fulton RA; Olsen KC; Pollock SJ; Serhan CN; Phipps RP; Sime PJ
PLoS One; 2013; 8(3):e58258. PubMed ID: 23484005
[TBL] [Abstract][Full Text] [Related]
10. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis.
Awojoodu AO; Ogle ME; Sefcik LS; Bowers DT; Martin K; Brayman KL; Lynch KR; Peirce-Cottler SM; Botchwey E
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13785-90. PubMed ID: 23918395
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
[TBL] [Abstract][Full Text] [Related]
14. Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury.
Chen J; Shetty S; Zhang P; Gao R; Hu Y; Wang S; Li Z; Fu J
Toxicol Appl Pharmacol; 2014 Jun; 277(2):118-23. PubMed ID: 24709673
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
Kang JW; Lee SM
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
[TBL] [Abstract][Full Text] [Related]
16. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages.
Recchiuti A; Codagnone M; Pierdomenico AM; Rossi C; Mari VC; Cianci E; Simiele F; Gatta V; Romano M
FASEB J; 2014 Jul; 28(7):3090-102. PubMed ID: 24692596
[TBL] [Abstract][Full Text] [Related]
17. Resolvin D1 prevents smoking-induced emphysema and promotes lung tissue regeneration.
Kim KH; Park TS; Kim YS; Lee JS; Oh YM; Lee SD; Lee SW
Int J Chron Obstruct Pulmon Dis; 2016; 11():1119-28. PubMed ID: 27313451
[TBL] [Abstract][Full Text] [Related]
18. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.
Abdulnour RE; Sham HP; Douda DN; Colas RA; Dalli J; Bai Y; Ai X; Serhan CN; Levy BD
Mucosal Immunol; 2016 Sep; 9(5):1278-87. PubMed ID: 26647716
[TBL] [Abstract][Full Text] [Related]
19. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
20. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
Rajasagi NK; Bhela S; Varanasi SK; Rouse BT
J Leukoc Biol; 2017 Nov; 102(5):1159-1171. PubMed ID: 28584076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
